Julio Cesar López-Cedillo

Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies

Isidro Palos, Edgar E. Lara‐Ramírez, Julio Cesar López-Cedillo et al. · Molecules · 2017 · 55 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

An in vitro and in vivo evaluation of new potential trans -sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method

Edgar E. Lara‐Ramírez, Julio Cesar López-Cedillo, Benjamín Nogueda‐Torres et al. · European Journal of Medicinal Chemistry · 2017 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Computational Medicinal Chemistry +12

In vitro and in vivo assessment of newer quinoxaline–oxadiazole hybrids as antimicrobial and antiprotozoal agents

Navin B. Patel, Jignesh N Patel, Amit C. Purohit et al. · International Journal of Antimicrobial Agents · 2017 · 26 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase

Muhammad Kashif, Karla Fabiola Chacón-Vargas, Julio Cesar López-Cedillo et al. · European Journal of Medicinal Chemistry · 2018 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Antibacterial activity of methanolic extracts from Dunaliella salina and Chlorella vulgaris

Nora Beatriz Medina-Jaritz, Luis Fernando Carmona‐Ugalde, Julio Cesar López-Cedillo et al. · The FASEB Journal · 2013 · 10 citations

Life Sciences, Marine Sciences, Microbiology +13